1. The 4S Study and its Pharmacoeconomic Implications

   • John P. D. Reckless

   Current Opinion 17 November 2012 Pages: 101 - 105

2. The Role of Public Opinion in Drug Resource Allocation Decisions

   • Catherine A. Melfi
   • Brenda G. Drake
   • William M. Tierney

   Leading Article 17 November 2012 Pages: 106 - 112

3. The Decision Rules of Cost-Effectiveness Analysis

   • Göran Karlsson
   • Magnus Johannesson

   Leading Article 17 November 2012 Pages: 113 - 120

4. The Prescription Drug User Fee Act of 1992

   • Sheila R. Shulman
   • Kenneth I. Kaitin

   Review Article 17 November 2012 Pages: 121 - 133

5. Clinical Issues Related to the Costs of Alcoholism

   • Matthew O. Howard
   • Robert W. McGuffin
   • R. Dale Walker

   Review Article 17 November 2012 Pages: 134 - 145

6. Economic Evaluation of an Educational Campaign for Early Diagnosis of Cutaneous Melanoma

   • Livio Garattini
   • Tullio Cainelli
   • Diego Scopelliti

   Original Research Article 17 November 2012 Pages: 146 - 155

7. Heart Failure

   • W. Guy Scott
   • Helen M. Scott

   Original Research Article 17 November 2012 Pages: 156 - 167

8. Propofol

   • Bret Fulton
   • Karen L. Goa

   Pharmacoeconomic Drug Evaluation 17 November 2012 Pages: 168 - 178